Promising survival rate but high incidence of treatment‐related mortality after reduced‐dose craniospinal radiotherapy and tandem high‐dose chemotherapy in patients with high‐risk medulloblastoma

BACKGROUND: In this study, we report the follow‐up results of reduced dose of craniospinal radiotherapy (CSRT) followed by tandem high‐dose chemotherapy (HDCT) in patients with high‐risk medulloblastoma (MB). METHODS: Newly diagnosed high‐risk MB patients (metastatic disease, postoperative residual...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Won, Lim, Do Hoon, Sung, Ki Woong, Cho, Hee Won, Ju, Hee Young, Hyun, Ju Kyung, Yoo, Keon Hee, Koo, Hong Hoe, Suh, Yeon‐Lim, Joung, Yoo‐Sook, Shin, Hyung Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433836/
https://www.ncbi.nlm.nih.gov/pubmed/32608158
http://dx.doi.org/10.1002/cam4.3199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433836/
https://www.ncbi.nlm.nih.gov/pubmed/32608158
http://dx.doi.org/10.1002/cam4.3199

Ejemplares similares